News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

David Holley, Xconomy Texas —  San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
Austin company purchases San Antonio’s ENTrigue Surgical for $45 million
July 3, 2013

ENTrigue Surgical Inc.'s balloon dilation system. The company has been bought out for $45 million.

By W. Scott Bailey, San Antonio Business Journal

ArthroCare Corp., an Austin-based developer and manufacturer of surgical products, has completed its acquisition of San Antonio's ENTrigue Surgical Inc., a privately held medical device company.

ArthroCare says it paid $45 million in cash to acquire ENTrigue, which primarily develops materials and medical devices for sinus-related surgeries.

More than 30 million people in the U.S. are estimated to suffer from sinusitis, which is a condition characterized by an inflammation and infection of the nasal sinuses. Approximately 500,000 sinusitis patients are treated surgically in the U.S. each year.

ENTrigue designs and develops innovative implants, disposables and instruments for endoscopic sinus surgery including balloon dilation. The company will now operate within ArthroCare's ENT product area as a complement to the company's Coblation and Rapid Rhino product lines currently being used by ENT surgeons worldwide.

 

Stay informed. Subscribe to BioMed SA news alerts.